Vectors Based on Epstein-Barr Virus

  • Paul M. Brickell
  • Mukesh Patel
Part of the Methods in Molecular Biology book series (MIMB, volume 8)


Vectors containing elements of the Epstein-Barr virus (EBV) genome are primarily used to maintain cloned DNA inserts as plasmids in mammalian cells. In addition, EBV-based vectors are proving to be valuable tools in elucidating details of EBV biology that have long eluded students of the virus. In this chapter, we will review those characteristics of EBV and its life cycle that have been used in vector construction and will describe methods that are particularly applicable to the use of EBV-based vectors.


Lytic Cycle Lytic Replication Lytic Phase Bovine Papilloma Virus Confer Hygromycin Resistance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Baer, R., Bankier, A. T., Biggin, M. D., Deininger, P. L., Farrell, P. J., Gibson, T. J., Hatfull, G., Hudson, G. S., Satchwell, S. G., Seguin, G., Tuffnell, P. S., and Barrell, B. G. (1984) DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310, 207–211.PubMedCrossRefGoogle Scholar
  2. 2.
    Speck, S. H. and Strominger, J. L. (1987) Epstein-Barr virus transformation. Prog. Nucleic Acid Res. Mol. Bwl. 34, 189–207.CrossRefGoogle Scholar
  3. 3.
    Dillner, J. and Kallin, B. (1988) The Epstein-Barr virus proteins. Adv. Cancer Res. 50, 95–158.PubMedCrossRefGoogle Scholar
  4. 4.
    Tosato, G. (1987) The Epstein-Barr virus and the immune system. Adv. Cancer Res. 49, 75–125.PubMedCrossRefGoogle Scholar
  5. 5.
    Dambaugh, T., Beisel, C, Hummel, M, King, W., Fennewald, S., Cheung, A., Heller, M., Raab-Traub, N., and Kieff, E. (1980) Epstein-Barr virus (B953) DNA VII: Molecular cloning and detailed mapping. Proc. Natl. Acad. Sci. USA 77, 2999–3003.PubMedCrossRefGoogle Scholar
  6. 6.
    Sugden, B., Phelps, M., and Domoradzki, J. (1979) Epstein-Barr virus is amplified in transformed lymphocytes. J. Virol. 31, 590–595.PubMedGoogle Scholar
  7. 7.
    Hampar, B., Tanaka, A., Nonoyama, M., and Derge, J. G. (1974) Replication of the resident repressed Epstein-Barr virus genome during the early S phase (S-1 period) of nonproducer Raji cells. Proc. Natl. Acad. Sci. USA 71, 631–633.PubMedCrossRefGoogle Scholar
  8. 8.
    Matsuo, T., Heller, M., Petti, L., O’shiro, E., and Kieff, E. (1984) Persistence of the entire Epstein-Barr virus genome integrated into human lymphocyte DNA. Science 226, 1322–1325PubMedCrossRefGoogle Scholar
  9. 9.
    Mecsas, J and Sugden, B. (1987) Replication of plasmids derived from bovine papilloma virus type I and Epstein-Barr virus in cells in culture. Annu. Rev. Cell. Biol. 3, 87–108.PubMedCrossRefGoogle Scholar
  10. 10.
    Laux, G., Perricaudet, M., and Farrell, P. J. (1988) Epstein-Barr virus gene expressed in immortalised lymphocytes is created by circularization of the viral genome. EMBO J. 7, 769–774.PubMedGoogle Scholar
  11. 11.
    Bhat, R. and Thimmappaya, B. (1983) Two small RNAs encoded by Epstein-Barr virus can functionally substitute for the virus-associated RNAs in the lytic growth of adenovirus 5. Proc. Natl Acad. Sci. USA 80, 4789–4793.PubMedCrossRefGoogle Scholar
  12. 12.
    Yates, J. L, Warren, N., and Sugden, B. (1985) Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313, 812–815.PubMedCrossRefGoogle Scholar
  13. 13.
    Reisman, D., Yates, J., and Sugden, B. (1985) A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol Cell. Biol. 5, 1822–1832.PubMedGoogle Scholar
  14. 14.
    Rawlins, D. R., Milman, G., Hayward, S. D., and Hayward, G. S. (1985) Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region. Cell 42, 659–668.CrossRefGoogle Scholar
  15. 15.
    Fried, M. and Prives, C. (1986) The biology of simian virus 40 and polyomavirus, in Cancer Cells-4. DNA Tumor Viruses: Control of Gene Expression and Replication (Botchan, M., Grodzicker, T., and Sharp, P. A., eds.), Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 1–16.Google Scholar
  16. 16.
    Reisman, D. and Sugden, B. (1986) Trans-activation of an Epstein-Barr viral transcription al enhancer by the Epstein-Barr viral nuclear antigen 1. Mol. Cell Biol 6, 3838–3846.PubMedGoogle Scholar
  17. 17.
    Sugden, B. and Warren, N. (1989) A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection. J. Virol. 63, 2644–2649PubMedGoogle Scholar
  18. 18.
    Jones, C. H., Hayward, S. D., and Rawlins, D. R. (1989) Interaction of the lymphocyte-derived Epstein-Barr virus nuclear antigen EBNA-1 with its DNA binding sites. J. Virol 63, 101–110.PubMedGoogle Scholar
  19. 19.
    Baichwal, V R. and Sugden, B. (1988) Latency comes of age for herpesviruses. Cell 52, 787–789.PubMedCrossRefGoogle Scholar
  20. 20.
    Hammerschmidt, W. and Sugden, B. (1988) Identification and characterization of onLyt, a lytic origin of DNA replication of Epstein-Barr virus Cell 55, 427–433.PubMedCrossRefGoogle Scholar
  21. 21.
    Sugden, B, Marsh, K., and Yates, J. (1985) A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus. Mol Cell. Biol. 5, 410–413.PubMedGoogle Scholar
  22. 22.
    Kioussis, D., Wilson, F., Daniels, C., Leveton, C., Taverne, J., and Playfair, J. H. L. (1987) Expression and rescuing of a cloned human tumour necrosis factor gene using an EBV-based shuttle cosmid vector. EMBO J. 6, 355–361.PubMedGoogle Scholar
  23. 23.
    Young, J. M., Cheadle, C, Foulke, J. S., Drohan, W. N., and Sarver, N. (1988) Utilization of an Epstein-Barr virus replicon as a eukaryotic expression vector. Gene 62, 171–185.PubMedCrossRefGoogle Scholar
  24. 24.
    Jalanko, A, Kallio, A., and Ultmanen, I. (1988) Comparison of mammalian cell expression vectors with and without an EBV-replicon. Arch. Virol. 103, 157–166.PubMedCrossRefGoogle Scholar
  25. 25.
    Groger, R. K., Morrow, D. M., and Tykocinski, M. L. (1989) Directional antisense and sense cDNA cloning using Epstein-Barr virus episomal expression vectors. Gene 81, 285–294.PubMedCrossRefGoogle Scholar
  26. 26.
    Drinkwater, N. R. and Klinedinst, D. K. (1986) Chemically induced mutagenesis in a shuttle vector with a low-background mutant frequency. Proc. Natl. Acad. Sci. USA 83, 3402–3406.PubMedCrossRefGoogle Scholar
  27. 27.
    DuBridge, R. B., Tang, P., Hsia, H. C, Leong, P.-M., Miller, J. H., and Calos, M. P. (1987) Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell Biol. 7, 379–387.PubMedGoogle Scholar
  28. 28.
    Hammerschmidt, W. and Sugden, B. (1989) Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 340, 393–397.PubMedCrossRefGoogle Scholar
  29. 29.
    Hirt, B. (1967) Selective extraction of polyoma DNA from infected mouse cell cultures J Mol Biol. 26, 365–369.PubMedCrossRefGoogle Scholar

Copyright information

© The Humana Press Inc., Clifton, NJ 1991

Authors and Affiliations

  • Paul M. Brickell
    • 1
  • Mukesh Patel
    • 1
  1. 1.Medical Molecular Biology UnitUniversity College and Middlesex School of MedicineLondonUK

Personalised recommendations